Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: RCMac who wrote (8382)	5/16/2003 1:31:57 PM
From: Biomaven	Respond to of 52153

Thanks RCM - that was indeed the article I saw. Reading it now, it strikes me that these instruments wouldn't benefit from the tax break, because they seem to be interest-based rather than dividend based. Ah, well - so much for that idea. However, the 8+% yields these offer are still attractive given the meager amounts you can get elsewhere. One of my pet investments looks like it is going away - these were the Gabelli Tax-Preferred B shares - they paid around 7% per annum in the form of long-term capital gains. Unfortunately it looks like they are being called, so I recently sold out. Peter